investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Fraser Symmans

1 Collaborator(s)

Funding source

University of Texas MD Anderson Cancer Center

Jonas Bergh

Karolinska Institute

Stockholm, Sweden

Related projects

Mien-Chie Hung

Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation

Breast

Jose Baselga

Unraveling resistance to PI3K-alpha inhibitors in breast cancer

Breast

Shyam Sharan

Functional Analysis of Human Breast Cancer Susceptibility Gene Variants

Breast

Joan Massague

TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression

Breast

Elizabeth Mittendorf

Immunologic Aspects of Triple Negative Breast Cancer and the Effects of Neoadjuvant Systemic Therapy

Breast

Marie C. Lee

Development of the Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk

Breast

Kevin Hughes Kensler

Androgen receptor expression and signaling and breast cancer risk and progression

Breast

Philip N Tsichlis

The role of IWS1 in development and tumorigenesis

Breast

Rong Li

Regulation of Hormone Production by Matrix Proteins

Breast